Can exogenous testosterone therapy cause liver injury?

Can Exogenous Testosterone Cause Liver Injury?

The risk of liver injury from exogenous testosterone depends critically on the formulation: oral testosterone preparations cause significant hepatotoxicity and should be avoided, while intramuscular and transdermal formulations do not appear to cause hepatic dysfunction and do not require routine liver function monitoring. 1

Formulation-Specific Hepatotoxicity

Oral Testosterone (17-α-alkylated preparations)

• Strongly discouraged and associated with serious hepatotoxicity 1
• Documented complications include:
  • Hepatocellular injury with elevated transaminases
  • Cholestatic syndrome
  • Peliosis hepatis (blood-filled cysts)
  • Benign hepatic adenomas
  • Hepatocellular carcinoma 2, 3, 4
• The 17-α-alkylation modification that allows oral absorption causes slower hepatic clearance, making these formulations particularly hepatotoxic 4
• Exception: Testosterone undecanoate does not appear to have appreciable hepatotoxicity but is not available in the United States 1

Intramuscular and Transdermal Testosterone

• Do not appear to be associated with hepatic dysfunction 1
• Routine monitoring with liver function tests is unnecessary for these formulations 1
• FDA labeling confirms rare reports of hepatocellular carcinoma only with long-term, high-dose androgen therapy 2

Important Clinical Distinctions

Supraphysiologic vs. Replacement Dosing

The hepatotoxicity risk increases substantially with:

• Supraphysiologic doses (abuse/performance enhancement)
• Multiple simultaneous steroid use
• Prolonged duration of high-dose therapy 2, 3, 4

Standard testosterone replacement therapy at physiologic doses using non-oral formulations carries minimal hepatic risk.

Hidden Supplement Risk

A critical pitfall: Over-the-counter "testosterone booster" supplements may contain undisclosed anabolic steroids and cause drug-induced liver injury 5, 4. Patients often fail to report supplements as medications, leading to missed diagnoses of hepatotoxicity 5. Always specifically ask about supplements when evaluating unexplained liver injury.

Monitoring Recommendations

For patients on intramuscular or transdermal testosterone:

• No routine liver function testing required 1
• Baseline assessment should focus on PSA, hematocrit/hemoglobin, and digital rectal exam 1
• Follow-up visits at 1-2 months initially, then 3-6 month intervals for the first year, then yearly 1

Clinical Bottom Line

Use only intramuscular or transdermal testosterone formulations for replacement therapy—these do not require liver monitoring. Avoid all oral testosterone preparations except testosterone undecanoate (if available). When evaluating unexplained liver injury, specifically inquire about supplement use, as patients rarely volunteer this information and supplements may contain hepatotoxic anabolic steroids.